Mastering Orthopedic Oncology Cases: Blastic Metastases Insights

Patient Presentation & History

A 70-year-old Caucasian male presented to the emergency department with acute onset left hip pain and inability to bear weight following a low-energy fall. The patient reported tripping over a rug in his living room, falling directly onto his left hip. He denied any significant prodromal pain, although he acknowledged a mild, intermittent ache in the left groin region over the preceding few weeks, which he attributed to age-related degenerative changes.

Demographics: 70-year-old male.

Chief Complaint: Acute, severe left hip pain and inability to ambulate.

Mechanism of Injury: Low-energy trauma (ground-level fall). This mechanism in an elderly patient, particularly with a known oncological history, immediately raises suspicion for a pathological fracture.

Past Medical History:
* Prostate Adenocarcinoma: Diagnosed 3 years prior (Gleason score 4+3=7). Initially treated with external beam radiation therapy and concurrent androgen deprivation therapy (ADT) with leuprolide. Follow-up PSA levels have shown a stable, albeit detectable, trend, indicating ongoing disease burden but no overt progression based on recent oncological assessments. He remains on long-term ADT.
* Hypertension: Well-controlled on lisinopril.
* Hyperlipidemia: On atorvastatin.
* Benign Prostatic Hyperplasia (BPH): Managed with tamsulosin.

Past Surgical History:
* Transureurethral resection of prostate (TURP) 10 years prior for BPH.

Medications: Leuprolide, Lisinopril, Atorvastatin, Tamsulosin. Denies use of bisphosphonates or denosumab.

Allergies: No known drug allergies.

Social History: Retired civil engineer. Lives independently in a single-story home with his spouse. Non-smoker, rarely consumes alcohol. No history of illicit drug use.

Review of Systems (focused):
* General: No fevers, chills, or night sweats. Reports mild generalized fatigue, which he attributes to his age and ongoing ADT. No significant recent unintended weight loss.
* Musculoskeletal: Localized severe pain in the left hip. No other acute joint pain.
* Neurological: No numbness, tingling, or weakness reported in the lower extremities prior to the fall. No bladder or bowel dysfunction.
* Oncological: No new urinary symptoms, hematuria, or obstructive symptoms.

The combination of advanced age, low-energy trauma, and a history of prostate cancer with its known propensity for blastic skeletal metastases strongly suggests a pathological fracture of the proximal femur. This necessitates a comprehensive orthopedic and oncologic evaluation.

Clinical Examination

Upon arrival, the patient was alert, oriented to person, place, and time, and appeared to be in significant acute distress secondary to pain.

General: Patient lying supine on the stretcher, favoring his left lower extremity, grimacing with any movement. Vital signs stable.

Inspection:
* Left Lower Extremity: Visibly shortened and held in an externally rotated position compared to the contralateral limb, consistent with a hip fracture.
* Skin: Intact skin with no open wounds, abrasions, or ecchymosis over the hip or thigh. No signs of infection or skin compromise.
* Swelling: Minimal local swelling noted around the proximal thigh and groin.
* Musculature: No obvious muscle atrophy.

Palpation:
* Tenderness: Exquisite tenderness to palpation over the left greater trochanter and anterior groin region. Any attempted movement of the left hip elicited severe pain.
* Masses: No palpable soft tissue masses in the hip or thigh.
* Crepitus: Mild crepitus elicited with gentle attempts at range of motion, indicating bony fragments.
* Warmth: No localized warmth or erythema.

Range of Motion (ROM):
* Left Hip: All active and passive movements were severely limited due to pain.
* Flexion: ~10-15 degrees (physiological flexion from the fracture position).
* Abduction/Adduction: Negligible.
* Internal/External Rotation: Severely painful and restricted, demonstrating fixed external rotation.
* Right Hip: Full, pain-free active and passive ROM.
* Knees/Ankles: Full, pain-free active and passive ROM bilaterally.

Neurological Assessment (Left Lower Extremity):
* Motor: Gross motor function was difficult to assess accurately due to pain. However, patient was able to weakly dorsiflex and plantarflex the ankle, and extend the great toe against gravity, suggesting gross nerve integrity. Specifically tested:
* L2/L3 (Hip flexion): Pain limited.
* L3/L4 (Knee extension): Pain limited.
* L4 (Ankle dorsiflexion): 3/5
* L5 (Great toe extension): 3/5
* S1 (Ankle plantarflexion): 3/5
* Sensory: Intact sensation to light touch across all dermatomes (L2-S1) in the left lower extremity. No areas of anesthesia or paresthesia.
* Reflexes: Patellar and Achilles reflexes 2+ bilaterally, symmetrical.
* Tone: Normal tone.
* No signs of cauda equina syndrome or acute spinal cord compression.

Vascular Assessment (Left Lower Extremity):
* Pulses: Dorsalis pedis and posterior tibial pulses 2+/2+, palpable and symmetrical with the contralateral side.
* Capillary Refill: <2 seconds in all toes.
* Temperature: Extremity was warm to touch.
* Color: Normal skin color.
* No signs of acute limb ischemia.

Other Relevant Findings:
* Cardiovascular and respiratory examinations were unremarkable, appropriate for age.
* Abdominal examination revealed no masses or tenderness.
* Examination of the contralateral (right) lower extremity and other joints was unremarkable, with no signs of pain, instability, or deformity.

The clinical presentation is highly consistent with a displaced, unstable fracture of the left proximal femur. The history of prostate cancer and the low-energy mechanism mandate further investigation to rule out a pathological origin due to metastatic disease.

Imaging & Diagnostics

Plain Radiographs:
* AP Pelvis, AP and Lateral Left Hip: These initial views revealed a comminuted, displaced, transverse subtrochanteric fracture of the left femur, approximately 5 cm distal to the lesser trochanter. The fracture pattern displayed significant comminution of the medial cortex.
* Bone Quality: The striking finding was the diffuse increase in bone density and sclerosis throughout the proximal femur, extending into the diaphyseal region. This "blastic" appearance, characterized by increased opacity and irregular trabecular thickening, is highly suggestive of metastatic prostate carcinoma.
* Cortical Involvement: Significant cortical thickening was observed, particularly on the medial and posterior aspects, with evidence of endosteal scalloping. Estimated cortical involvement was greater than 50% of the circumference in the fracture zone.
* Mirels' Score: While the fracture was already present, a hypothetical Mirels' score for the lesion (assuming it was an impending fracture) would have been high (>9), given the location (subtrochanteric), size (>2/3 cortical involvement), nature (blastic), and presence of severe pain prior to fracture.

Computed Tomography (CT) of Left Femur with 3D Reconstruction:
* Detailed Fracture Anatomy: Confirmed the comminuted, transverse subtrochanteric fracture. Provided superior detail regarding the exact fracture lines, fragment displacement, and extent of comminution, which was crucial for surgical planning.
* Lesion Characterization: Clearly delineated the extensive blastic metastatic disease throughout the proximal and mid-diaphyseal femur. The sclerotic foci were dense and heterogeneous, consistent with osteoblastic activity. The CT allowed for precise measurement of cortical destruction and involvement, confirming >50% cortical compromise at the fracture site.
* Soft Tissue Assessment: No significant soft tissue mass or extra-osseous extension was identified, which would be atypical for blastic prostate metastases.
* 3D Reconstruction: Provided invaluable visual understanding of the complex fracture morphology and the spatial relationship of the fragments, aiding in templating for implant selection (nail length, diameter) and predicting reduction maneuvers. This confirmed the need for a long intramedullary nail to bypass the entire diseased segment.

Magnetic Resonance Imaging (MRI) of Left Femur and Whole Spine:
* Marrow Involvement: While CT excels at cortical detail, MRI provided detailed assessment of marrow infiltration. T1-weighted sequences showed diffuse low signal intensity within the proximal femoral marrow, replacing normal fatty marrow, consistent with widespread tumor infiltration. STIR (Short Tau Inversion Recovery) sequences showed areas of high signal intensity, indicative of active edema and viable tumor.
* Soft Tissue Extension: Confirmed minimal to no significant soft tissue mass surrounding the fracture, primarily confined to the bone.
* Lesion Activity: Helped differentiate between active metastatic deposits and quiescent sclerotic bone changes.
* Multi-focal Disease: Whole spine MRI (performed as part of the initial metastatic workup and re-evaluated) showed multiple small blastic lesions in the lumbar and thoracic vertebral bodies, confirming multi-focal skeletal metastasis. No evidence of spinal cord compression or impending instability in the spine.

Technetium-99m MDP Bone Scan:
* Whole-Body Staging: Demonstrated multiple foci of abnormally increased radiotracer uptake throughout the axial and appendicular skeleton. Intense uptake was noted in the left proximal femur corresponding to the fracture site and the widespread blastic lesions seen on other imaging. Additional foci were noted in the lumbar spine (L3, L4, S1), sacrum, and right iliac wing, confirming widespread skeletal metastatic disease. This validated the suspicion of multi-focal involvement.

Laboratory Investigations:
* Full Blood Count (FBC): Mild normocytic, normochromic anemia (Hb 11.2 g/dL), consistent with anemia of chronic disease. White blood cell count and platelet count were within normal limits.
* Basic Metabolic Panel (BMP): Electrolytes, blood urea nitrogen (BUN), and creatinine were within normal limits, indicating normal renal function. Calcium was slightly elevated at 10.8 mg/dL (normal 8.5-10.5 mg/dL), which can occur with extensive blastic disease, although hypercalcemia is more typical of lytic lesions.
* Liver Function Tests (LFTs): Within normal limits.
* Coagulation Profile: Prothrombin Time (PT), Activated Partial Partial Thromboplastin Time (aPTT), and International Normalized Ratio (INR) were all within normal limits, providing surgical clearance.
* Tumor Markers:
* Prostate-Specific Antigen (PSA): Markedly elevated at 154 ng/mL (prior stable levels were around 40-50 ng/mL on ADT), indicating disease progression or increased tumor burden. This rise correlates with the acute pathological event.
* Alkaline Phosphatase (ALP): Significantly elevated at 280 U/L (normal 40-120 U/L), reflecting high osteoblastic activity associated with widespread blastic metastases.
* Serum Protein Electrophoresis (SPEP) / Urine Protein Electrophoresis (UPEP): Not indicated given the known prostate cancer and predominantly blastic nature of the lesions, making multiple myeloma less likely.
* Vitamin D, Parathyroid Hormone (PTH): Not routinely performed in this acute setting but considered in long-term management with bone-modifying agents.

Biopsy:
* Given the known history of prostate adenocarcinoma, the classic blastic radiographic appearance, and the clear evidence of widespread metastatic disease, a pre-operative percutaneous biopsy was deemed unnecessary. An intraoperative core biopsy from the fracture site was planned to confirm the metastatic nature and primary origin, allowing for definitive histopathological diagnosis and immunohistochemical analysis if needed. This approach avoided additional invasive procedures and potential delay in definitive surgical stabilization.

Differential Diagnosis

The clinical presentation and initial imaging findings in a patient with known prostate cancer strongly point towards a pathological fracture secondary to metastatic disease. However, it is crucial to consider other potential pathologies that can cause sclerotic bone lesions and pathological fractures in this age group.

Rationale for Ruling Out Other Differentials in this Case:
1. Multiple Myeloma: The patient's presentation with purely blastic lesions and a known prostate cancer history makes myeloma highly unlikely. Myeloma typically presents with lytic, "punched-out" lesions. While rare sclerotic variants exist, the clinical picture and markedly elevated PSA are not consistent.
2. Paget's Disease of Bone: While Paget's can cause extensive bone thickening, sclerosis, and pathological fractures in weight-bearing bones of elderly individuals, its radiographic appearance often has a more characteristic "cotton wool" or "flame-shaped" lytic-sclerotic front, with bone expansion and coarsened trabeculae, which differs from the dense, somewhat infiltrative blastic pattern seen here. Critically, the patient's markedly elevated PSA and known prostate cancer history are absent in Paget's, and ALP would be elevated, but PSA would not.
3. Primary Osteosarcoma: A primary osteosarcoma in a 70-year-old would be less common in the subtrochanteric region and typically presents with a more aggressive periosteal reaction and a soft tissue mass. While sclerotic subtypes exist, the multifocal nature of the bone scan and the known history of widespread prostate cancer makes a primary de novo tumor less probable, although an osteosarcoma arising in Paget's bone could be a consideration, but again, the PSA and specific imaging are more consistent with metastasis.

Based on the strong clinical correlation, classic radiographic findings of blastic lesions, known primary prostate adenocarcinoma, and widespread skeletal involvement on bone scan, metastatic prostate carcinoma is the overwhelming working diagnosis. An intraoperative biopsy will provide definitive confirmation.

Surgical Decision Making & Classification

Why Operative vs. Non-operative?

The decision for surgical intervention in this case was straightforward and made with the primary goals of pain relief, functional restoration, prevention of complications from immobility, and maintenance of quality of life.

• Pathological Fracture: The patient sustained a displaced, unstable subtrochanteric fracture. Non-operative management of such a fracture in an oncological patient would lead to:
  • Intractable Pain: Persistent severe pain due to instability, requiring high doses of analgesics.
  • Immobility Complications: Prolonged bed rest would precipitate complications such as deep vein thrombosis (DVT), pulmonary embolism (PE), pneumonia, pressure ulcers, muscle atrophy, joint contractures, and deconditioning. These complications significantly impair recovery and can be life-threatening.
  • Poor Quality of Life: Inability to ambulate, even with assistance, severely restricts independence and quality of life, which is a paramount concern in palliative cancer care.
  • Delayed Oncologic Treatment: Persistent pain and immobility can delay or preclude the administration of vital adjuvant oncological therapies.
• Life Expectancy: For patients with metastatic disease to weight-bearing bones, the general consensus is that if the estimated life expectancy is 6-12 weeks or more, surgical stabilization is beneficial. With known but stable prostate cancer on ADT, this patient's prognosis is likely several months to years, easily meeting the threshold for surgical intervention. The sudden increase in PSA suggests disease progression but does not negate the benefits of stabilizing a pathological fracture.
• Rehabilitation Potential: The patient was otherwise healthy and independent prior to the fall, indicating good baseline functional status and a strong potential for post-operative rehabilitation and return to a reasonable level of mobility.

Specific Classifications Used in Decision Making:

1. Mirels' Classification System:

   • Although the fracture was already complete, this system is invaluable for assessing impending pathological fractures and helps guide prophylactic fixation.
   • Score Calculation for the lesion (if impending):
     • Location: Lower extremity (trochanteric region) = 2 points.
     • Size: Cortical involvement >2/3 (observed on imaging) = 3 points.
     • Nature: Blastic = 1 point.
     • Pain: Severe pain (prior to fall, now acute pain) = 3 points.
     • Total Score = 9 points.
   • Interpretation: A Mirels' score of 7 or higher is a strong indication for prophylactic surgical stabilization. This case, with a score of 9, unequivocally supports surgical intervention, especially given the actual fracture.

2. AO/OTA Fracture Classification Principles:

   • While not a specific "pathological fracture" classification, the principles of AO/OTA (e.g., Type 32-A3.3 for a comminuted subtrochanteric fracture) guided the understanding of fracture complexity, stability, and the choice of fixation. The significant comminution and poor bone quality due to the blastic metastasis underscore the need for a robust, load-sharing implant.

3. Enneking Staging System (Applicability to Metastatic Disease):

   • Primarily developed for primary bone sarcomas, the Enneking system is used to describe the biological aggressiveness and anatomical extent of a tumor. While not directly applied to the fracture itself, the overarching context is of a patient with Stage III metastatic disease (regional/distant metastasis), which informs the overall oncologic management strategy alongside the orthopedic intervention. This classification emphasizes the need for a multidisciplinary approach.

Surgical Decision:

Based on the clinical presentation of an unstable, painful pathological subtrochanteric fracture in a 70-year-old male with widespread blastic prostate cancer and an excellent functional prognosis for surgical stabilization, the decision was made for surgical stabilization using a long cephalomedullary intramedullary nail. This implant choice is preferred for subtrochanteric fractures, particularly pathological ones, as it provides strong internal fixation, can be extended to bypass the entire diseased segment of the femur, and prophylactically protects the diaphysis from future fractures.

Surgical Technique / Intervention

Pre-operative Planning:
1. Imaging Review: Thorough review of plain radiographs, CT with 3D reconstructions, and MRI to meticulously characterize the fracture pattern, extent of blastic lesions, bone quality, and to confirm the optimal entry point and trajectory for the intramedullary nail.
2. Templating: Digital templating was performed using CT images to determine the appropriate nail length (ensuring bypass of the entire diseased segment and extending to the knee joint), nail diameter, and optimal lag screw/cephalic screw trajectory. A long cephalomedullary nail system was chosen.
3. Multidisciplinary Conference: Case discussed with medical oncology and radiation oncology teams. It was agreed that surgical stabilization was the priority, to be followed by local radiation therapy once the surgical wound had healed and adjuvant systemic therapy adjusted as needed.
4. Patient Optimization: Pre-operative medical optimization, including DVT prophylaxis education, nutritional assessment, and anemia correction (if required), was performed. Blood products were cross-matched in anticipation of potential intraoperative blood loss.

Patient Positioning:
1. The patient was positioned supine on a radiolucent fracture table. The contralateral limb was abducted in a well-padded boot to allow for adequate fluoroscopic imaging of the entire fractured femur.
2. The affected left limb was placed in traction, providing controlled distraction and facilitating preliminary reduction efforts.
3. Careful padding was applied to all pressure points, particularly the perineum, heels, and arms, to prevent iatrogenic pressure injuries during the potentially prolonged procedure.

Surgical Approach:
1. A standard lateral approach to the greater trochanter was utilized. A longitudinal skin incision approximately 5-7 cm in length was made, centered over the tip of the greater trochanter.
2. The subcutaneous tissues were dissected, and the fascia lata was incised longitudinally. The vastus lateralis muscle was split or incised sharply to expose the proximal femur and the entry point for the intramedullary nail.

Reduction Techniques:
1. Initial gross reduction was achieved via closed manipulation using the fracture table, applying longitudinal traction and gentle internal rotation. Fluoroscopy was used to assess alignment in both AP and lateral planes.
2. Given the comminution and the altered bone density from the blastic metastasis, achieving perfect anatomical reduction was not the primary goal; rather, acceptable alignment with restoration of length, rotation, and angulation was prioritized to facilitate nail passage.
3. If closed reduction was challenging due to fragment interposition or severe comminution, a limited open reduction via the same incision or a small accessory incision would have been considered, using reduction clamps or temporary K-wires. In this case, acceptable alignment was achieved with traction and gentle manipulation.

Fixation Construct (Long Cephalomedullary Intramedullary Nail):
1. Entry Point: The entry point for the intramedullary nail was precisely located at the tip of the greater trochanter (or piriformis fossa depending on the nail system), confirmed with fluoroscopy. A guide wire was inserted, and an awl or drill was used to open the femoral canal.
2. Reaming: Sequential, gentle intramedullary reaming was performed using flexible reamers. Due to the blastic nature of the bone, which can be dense but brittle, reaming was done cautiously and incrementally (e.g., 0.5 mm increments) to create a canal slightly larger than the chosen nail diameter. This minimized the risk of iatrogenic fracture propagation or jamming the reamer within the dense bone. Copious irrigation was used to minimize thermal necrosis.
3. Nail Insertion: A selected long cephalomedullary nail (e.g., 12 mm diameter, 380 mm length), chosen to bypass the entire blastic lesion and extend to the distal femoral metaphysis, was inserted over the guide wire. Insertion was performed carefully with gentle impaction, ensuring correct rotational alignment. Fluoroscopy was used to monitor nail progression and ensure it bypassed the distal extent of the blastic disease.
4. Proximal Fixation: Once the nail was seated, proximal interlocking was performed. Two lag screws (e.g., 8.0 mm diameter) were inserted into the femoral head and neck, guided by the nail's aiming device and confirmed with fluoroscopy in AP and lateral views. These screws provided stable fixation of the femoral head segment to the nail.
5. Distal Locking: Distal interlocking was achieved using an aiming guide or freehand technique under fluoroscopic control. Two distal interlocking screws (e.g., 5.0 mm diameter) were inserted perpendicular to the long axis of the nail. Static locking was employed to prevent shortening and rotation, providing maximum stability in this pathological fracture.
6. Intraoperative Biopsy: A core biopsy was obtained from the fracture site prior to nail insertion, or from an adjacent area of blastic bone through the same approach. The samples were sent for routine histopathological examination and immunohistochemistry (IHC) to confirm metastatic adenocarcinoma of prostate origin.

Wound Closure:
1. The surgical site was thoroughly irrigated. Meticulous hemostasis was achieved.
2. The vastus lateralis was reapproximated, followed by closure of the fascia lata.
3. Subcutaneous tissues and skin were closed in layers using absorbable sutures and skin staples, respectively. A sterile dressing was applied. No drain was typically placed unless significant bleeding was encountered.

Fluoroscopy:
* Continuous and intermittent fluoroscopy was used throughout the procedure to confirm all steps: guide wire placement, reaming, nail insertion, rotational alignment, proximal and distal interlocking screw placement, and final fracture reduction and implant position. Image intensifier time was carefully monitored.

Post-Operative Protocol & Rehabilitation

Immediate Post-Operative Period (Hospital Stay):
* Pain Management: A multimodal analgesic regimen was instituted, including patient-controlled analgesia (PCA) initially, transitioning to oral opioids, acetaminophen, and NSAIDs (if not contraindicated). Nerve blocks (e.g., fascia iliaca block) were considered pre-operatively or immediately post-operatively for enhanced pain control.
* Deep Vein Thrombosis (DVT) Prophylaxis: Pharmacological DVT prophylaxis (e.g., low molecular weight heparin) was initiated on post-operative day 0, in addition to mechanical prophylaxis (intermittent pneumatic compression devices). This is crucial in oncological patients with lower extremity trauma.
* Wound Care: Daily wound checks for signs of infection or hematoma. Staples typically removed at 14-21 days post-op.
* Early Mobilization: The cornerstone of post-operative management. On post-operative day 1, the patient was encouraged to sit out of bed, perform ankle pumps, and initiate gentle hip and knee range of motion exercises.
* Weight-Bearing Status: Given the stable fixation with a long cephalomedullary nail bypassing the lesion and the blastic nature of the bone (which tends to be dense but brittle, rather than purely lytic and poorly supportive), the patient was allowed immediate protected weight-bearing (toe-touch or partial weight-bearing) with the assistance of a walker or crutches. The progression of weight-bearing was guided by pain tolerance and radiological assessment.

Rehabilitation (Outpatient/Inpatient Rehabilitation):
* Physical Therapy (PT):
* Phase 1 (Early Mobilization): Focus on regaining hip and knee range of motion, isometric strengthening, transfers, and gait training with assistive devices (walker, then crutches). Education on fall prevention.
* Phase 2 (Progressive Strengthening): Once initial pain subsides and wound healing is adequate, a gradual increase in weight-bearing as tolerated. Progression to strengthening exercises for hip abductors, adductors, extensors, and quadriceps. Core stability exercises.
* Phase 3 (Functional Independence): Aiming for return to pre-morbid functional status as much as possible, focusing on endurance, balance, and advanced gait training.
* Occupational Therapy (OT): Assessment and training for activities of daily living (ADLs), adaptive equipment, and home modifications to ensure a safe discharge.

Oncologic Management:
* Adjuvant Radiation Therapy (PORT): Post-operative radiation therapy (typically 30 Gy in 10 fractions) was planned for the operative site. This is often initiated 2-3 weeks post-surgery, once the surgical wound has adequately healed. The goal is to provide local tumor control, reduce post-operative pain, and potentially reduce the risk of implant failure or local recurrence, although radiation can sometimes delay bone healing.
* Systemic Therapy: Close collaboration with the medical oncologist to reassess and adjust systemic anti-cancer therapy. This included continuing androgen deprivation therapy and considering other agents such as chemotherapy, novel hormonal agents (e.g., enzalutamide, abiraterone), or bone-modifying agents.
* Bone-Modifying Agents (BMAs): Initiation of intravenous zoledronic acid or subcutaneous denosumab was considered to reduce the risk of future skeletal-related events (SREs), including further pathological fractures, spinal cord compression, and hypercalcemia.

Follow-up:
* Orthopedic Follow-up: Regular clinical and radiographic evaluations at 2 weeks (for wound check/staple removal), 6 weeks, 3 months, 6 months, and annually thereafter, or as clinically indicated. X-rays were obtained to monitor fracture healing, implant integrity, and detect any signs of loosening or hardware failure.
* Oncological Follow-up: As per the medical oncologist's protocol, including regular PSA monitoring, repeat bone scans, and other imaging (e.g., CT chest/abdomen/pelvis) to monitor disease progression.
* Pain Management Clinic: Referral to a chronic pain management service if persistent pain issues arise.

Pearls & Pitfalls (Crucial for FRCS/Board Exams)

Pearls

1. High Index of Suspicion for Pathological Fractures: In any adult, particularly elderly patients, presenting with a low-energy fracture and a history of cancer (especially prostate, breast, lung, kidney, thyroid, myeloma), always suspect a pathological fracture until proven otherwise. This guides initial workup and treatment strategy.
2. Mirels' Score as a Prophylactic Guide: Prophylactic fixation of impending pathological fractures (Mirels' score ≥ 7) is almost always preferable to managing an acute fracture. It is less morbid, technically easier, and yields better functional outcomes. Always apply this score even when a fracture is present to understand the underlying lesion's instability.
3. Bypass the Lesion: The implant must extend well beyond the entire segment of diseased bone. For diaphyseal or subtrochanteric femoral lesions, a long cephalomedullary intramedullary nail should extend to at least the knee joint (or as distally as possible into healthy bone) to provide adequate fixation and prevent re-fracture at the implant tip or just adjacent to the initial lesion.
4. Long Intramedullary Nails for Femur: For pathological subtrochanteric and diaphyseal femoral fractures, long IM nails are the gold standard. They provide load-sharing stability, allow for early weight-bearing, and prophylactically protect the remaining diseased femur.
5. Biopsy is Non-Negotiable: Even with a known primary tumor and classic imaging, an intraoperative biopsy is essential. It confirms the metastatic nature, the primary origin (if unknown or atypical), and provides tissue for immunohistochemistry and molecular profiling, which can guide systemic oncologic management.
6. Multidisciplinary Approach: Successful management of orthopedic oncology cases necessitates close collaboration with medical oncology, radiation oncology, palliative care, and rehabilitation specialists. Orthopedic surgeons are part of a larger team.
7. Adjuvant Radiation Therapy: Post-operative radiation therapy is typically indicated for pathological fractures due to metastasis to improve local control, reduce pain, decrease tumor burden, and potentially reduce the risk of non-union or implant failure. Timing is crucial – usually initiated after wound healing.
8. Bone Cement Augmentation (PMMA): For large lytic defects, PMMA cement can be invaluable. It fills voids, augments screw fixation in compromised bone, and provides immediate load-bearing capabilities. While less critical for purely blastic lesions, it can be useful if significant lytic components exist or if there are large cortical defects post-reduction.
9. Early Protected Weight-Bearing: Aim for immediate protected weight-bearing (toe-touch or partial weight-bearing) with stable fixation. This prevents complications of immobility, promotes functional recovery, and significantly improves the patient's quality of life.

Pitfalls

1. Inadequate Implant Length: Using an implant that is too short or does not bypass the entire tumor-involved segment will inevitably lead to re-fracture or new fracture propagation at the implant tip.
2. Underestimation of Bone Quality: Metastatic bone, whether lytic or blastic, is structurally compromised. Aggressive reaming, forceful reduction, or inadequate screw purchase can lead to iatrogenic fractures or hardware failure. Gentle technique and careful handling are paramount.
3. Misdiagnosis / No Biopsy: Assuming a metastasis without histological confirmation, especially if the primary is unknown or imaging is atypical, can lead to inappropriate treatment. Always biopsy.
4. Failure to Evaluate for Multi-focal Disease: Not performing a whole-body bone scan or comprehensive staging imaging can miss other synchronous metastatic lesions, potentially leading to future pathological fractures elsewhere.
5. Ignoring Systemic Disease: Focusing solely on the orthopedic fracture without integrating the patient's overall oncologic management plan is a critical error. The orthopedic intervention is part of a larger palliative or curative strategy.
6. Suboptimal Post-operative Management: Neglecting DVT prophylaxis, inadequate pain control, or delaying early mobilization can lead to severe complications that undermine the benefits of successful surgery.
7. Delayed or Inappropriate Adjuvant Therapy: Failure to coordinate with radiation oncology or medical oncology regarding post-operative radiation and systemic therapy can compromise local control and overall patient outcomes.
8. Hardware Failure: Pathological fractures are at higher risk of non-union and hardware failure due to poor bone quality, tumor progression, and compromised healing potential. Close follow-up and consideration of bone-modifying agents are critical.
9. Perioperative Bleeding: Some metastatic lesions (e.g., renal cell carcinoma, thyroid carcinoma) are highly vascular. While prostate metastases are usually less vascular, significant bleeding can still occur, necessitating careful hemostasis and blood product availability.
10. Neurological Complications: Although less common with extremity fractures, always rule out concomitant spinal metastases leading to instability or cord compression, especially if there are any neurological symptoms.